Methotrexate versus Cyclosporine in Moderate-to-Severe Chronic Plaque Psoriasis
2003; Massachusetts Medical Society; Volume: 349; Issue: 7 Linguagem: Inglês
10.1056/nejmoa021359
ISSN1533-4406
AutoresVera M. R. Heydendael, Phyllis I. Spuls, Brent C. Opmeer, Corianne A.J.M. de Borgie, Johannes B. Reitsma, Wouter F.M. Goldschmidt, Patrick M. Bossuyt, Jan D. Bos, Menno A. de Rie,
Tópico(s)Rheumatoid Arthritis Research and Therapies
ResumoMethotrexate and cyclosporine are well-known systemic therapies for moderate-to-severe chronic plaque psoriasis. We conduced a randomized, controlled trial comparing methotrexate and cyclosporine in terms of effectiveness, side effects, and the quality of life.
Referência(s)